Pharma Mar S.A. Logo

Pharma Mar S.A.

Biopharmaceutical company developing oncology treatments from marine sources.

PHM | MC

Overview

Corporate Details

ISIN(s):
ES0169501022 (+1 more)
LEI:
959800QWKZ45ZQC2AV58
Country:
Spain
Address:
Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo

Description

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-19 17:40
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
Spanish 183.1 KB
2025-05-19 08:26
La Sociedad anuncia que su socio Adium Pharma S.A. ha recibido la aprobación pa…
Spanish 751.5 KB
2025-05-13 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-05-12 17:38
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
Spanish 165.2 KB
2025-05-06 11:42
La Sociedad remite anuncio de convocatoria de la Junta General Ordinaria de Acc…
Spanish 495.5 KB
2025-05-06 00:00
La Sociedad remite anuncio de convocatoria de la Junta General Ordinaria de Acc…
Spanish 495.5 KB
2025-05-05 17:38
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
Spanish 195.0 KB
2025-04-29 09:51
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
Spanish 165.4 KB
2025-04-24 17:48
La Sociedad comunica la decisión del Consejo de Administración de convocar Junt…
Spanish 214.4 KB
2025-04-24 17:41
La Sociedad publica información financiera correspondiente al primer trimestre …
Spanish 928.1 KB
2025-04-24 00:00
La Sociedad comunica la decisión del Consejo de Administración de convocar Junt…
Spanish 214.4 KB
2025-04-21 17:22
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
Spanish 158.5 KB
2025-04-14 17:41
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
Spanish 177.4 KB
2025-04-08 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2025-04-08 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB

Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharma Mar S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.